BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6273503)

  • 1. Biochemical transformation of mouse cells by varicella-zoster virus.
    Yamanishi K; Matsunaga Y; Ogino T; Lopetegui P
    J Gen Virol; 1981 Oct; 56(Pt 2):421-30. PubMed ID: 6273503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxythymidine kinases in varicella-zoster virus infected and biochemically transformed cells.
    Ogino T; Lopetegui P; Yamanishi K
    Biken J; 1982 Sep; 25(3):149-56. PubMed ID: 6299267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of the varicella zoster virus deoxypyrimidine kinase gene and preliminary identification of its transcript.
    Sawyer MH; Ostrove JM; Felser JM; Straus SE
    Virology; 1986 Feb; 149(1):1-9. PubMed ID: 3004022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of thymidine kinase activity in mouse L cells biochemically transformed by varicella-zoster virus.
    Shiraki K; Mori H; Hayakawa Y; Yamanishi K; Takahashi M
    Microbiol Immunol; 1989; 33(8):693-8. PubMed ID: 2550747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by interferon of herpes simplex virus thymidine kinase and DNA polymerase in infected and biochemically transformed cells.
    Panet A; Falk H
    J Gen Virol; 1983 Sep; 64 (Pt 9)():1999-2006. PubMed ID: 6193244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a herpes simplex virus/varicella-zoster virus (HSV/VZV) thymidine kinase recombinant with the pathogenic potential of HSV and a drug sensitivity profile resembling that of VZV.
    Bevilacqua F; Davis-Poynter N; Worrallo J; Gower D; Collins P; Darby G
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1927-35. PubMed ID: 7636473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of varicella-zoster virus-related antigens in biochemically transformed cells.
    Lopetegui P; Matsunaga Y; Okuno T; Ogino T; Yamanishi K
    J Gen Virol; 1983 May; 64(Pt 5):1181-6. PubMed ID: 6302213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella-zoster virus-induced transformation of mammalian cells in vitro.
    Gelb L; Dohner D
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):77s-81s. PubMed ID: 6330228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical characterization of pyrimidine kinase induced by varicella-zoster virus.
    Shiraki K; Ogino T; Yamanishi K; Takahashi M
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():221-9. PubMed ID: 2981965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine kinase gene transfer by herpes simplex virus.
    Kraiselburd E
    Bull Cancer; 1976; 63(3):393-8. PubMed ID: 187268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine into deoxyribonucleic acids of varicella-zoster virus (TK+ and TK- strains)-infected cells.
    Yokota T; Konno K; Shigeta S; Verbruggen A; De Clercq E
    Mol Pharmacol; 1987 May; 31(5):493-9. PubMed ID: 3033468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfection with the isolated herpes simplex virus thymidine kinase genes. II. Evidence for amplification of viral and adjacent cellular DNA sequences.
    Reyes GR; McLane MW; Hayward GS
    J Gen Virol; 1982 Jun; 60(Pt 2):209-24. PubMed ID: 6286848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant of herpes simplex virus type 1 conditionally able to transform thymidine kinaseless L cells to a tk+ phenotype.
    Hughes RG; Munyon WH
    J Virol; 1976 Jun; 18(3):867-72. PubMed ID: 178926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of nucleotide sequence variations in herpes simplex virus types 1 and 2, and varicella-zoster virus.
    Chiba A; Suzutani T; Saijo M; Koyano S; Azuma M
    Acta Virol; 1998 Dec; 42(6):401-7. PubMed ID: 10358747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and persistent varicella-zoster virus infection of human and murine neuroblastoma cell lines.
    Bourdon-Wouters C; Merville-Louis MP; Sadzot-Delvaux C; Marc P; Piette J; Delrée P; Moonen G; Rentier B
    J Neurosci Res; 1990 May; 26(1):90-7. PubMed ID: 2162972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical transformation of mouse cells by fragments of herpes simplex virus DNA.
    Maitland NJ; McDougall JK
    Cell; 1977 May; 11(1):233-41. PubMed ID: 194705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human ocular-derived virus-specific CD4+ T cells control varicella zoster virus replication in human retinal pigment epithelial cells.
    Milikan JC; Baarsma GS; Kuijpers RW; Osterhaus AD; Verjans GM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):743-51. PubMed ID: 18936136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H
    Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of oxetanocins against varicella-zoster virus.
    Sakuma T; Saijo M; Suzutani T; Yoshida I; Saito S; Kitagawa M; Hasegawa S; Azuma M
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1512-4. PubMed ID: 1656865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.